Bill SponsorBILLSPONSOR
Bill Sponsor
Politicians
Bills
Senate Bill 2658
115th Congress(2017-2018)
Protecting Newborns from Opioids Act
Introduced
Introduced
Introduced in Senate on Apr 12, 2018
Overview
Text
Introduced in Senate 
Apr 12, 2018
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Introduced in Senate(Apr 12, 2018)
Apr 12, 2018
Not Scanned for Linkage
About Linkage
Multiple bills can contain the same text. This could be an identical bill in the opposite chamber or a smaller bill with a section embedded in a larger bill.
Bill Sponsor regularly scans bill texts to find sections that are contained in other bill texts. When a matching section is found, the bills containing that section can be viewed by clicking "View Bills" within the bill text section.
Bill Sponsor is currently only finding exact word-for-word section matches. In a future release, partial matches will be included.
Jump To
S. 2658 (Introduced-in-Senate)


115th CONGRESS
2d Session
S. 2658


To amend the Public Health Service Act to provide for systematic data collection, analysis, and epidemiological research regarding neonatal abstinence syndrome.

IN THE SENATE OF THE UNITED STATES

April 12, 2018

Mr. Nelson (for himself and Mr. Rubio) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions

A BILL

To amend the Public Health Service Act to provide for systematic data collection, analysis, and epidemiological research regarding neonatal abstinence syndrome.

Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,

SECTION 1. Short title.

This Act may be cited as the “Protecting Newborns from Opioids Act”.

SEC. 2. Neonatal abstinence syndrome research and surveillance.

Title III of the Public Health Service Act is amended by inserting after section 317L–1 (42 U.S.C. 247b–13a) the following:

“SEC. 317L–2. Neonatal abstinence syndrome research and surveillance.

“(a) In general.—The Secretary, acting through the Director of the Centers for Disease Control and Prevention (referred to in this section as the ‘Director’), shall—

“(1) award grants to States to create or improve surveillance systems for neonatal abstinence syndrome, and analyze the data collected through such State systems; and

“(2) conduct research on the prevention, factors surrounding, and health outcomes of neonatal abstinence syndrome.

“(b) NAS surveillance.—

“(1) STATE GRANT PROGRAM.—To provide support to States receiving grants under subsection (a)(1), the Secretary shall (directly or through grants or cooperative agreements to public and nonprofit private entities)—

“(A) cooperate with and assist States in implementing a State-wide surveillance system to rapidly determine the incidence and prevalence of neonatal abstinence syndrome;

“(B) include demographics and other information, such as race, ethnicity, geographic location, and family history;

“(C) provide technical assistance to States to improve identification of neonatal abstinence syndrome;

“(D) ensure a pathway for data sharing between States and the Centers for Disease Control and Prevention; and

“(E) ensure that data collection is consistent with applicable State and Federal privacy laws.

“(2) CDC RESEARCH.—The Director shall—

“(A) collect data on neonatal abstinence syndrome that States gather using grant funds under subsection (a)(1);

“(B) conduct analysis of such data to identify national trends; and

“(C) issue public reports on such analysis.

“(c) NAS research.—In carrying out subsection (a)(2), the Secretary shall conduct new studies, or capitalize on existing studies, to research—

“(1) long-term physical, educational, and neu­ro­de­vel­op­ment­al outcomes of children affected by neonatal abstinence syndrome;

“(2) the prevalence of, and reasons for, opioid use among women who are pregnant or may become pregnant; and

“(3) the comparative effectiveness of available treatment protocols for infants affected by neonatal abstinence syndrome.

“(d) Authorization of appropriations.—To carry out this section, there is authorized to be appropriated such sums as may be necessary for each of fiscal years 2019 through 2023.”.